K243294 is an FDA 510(k) clearance for the Brainomix 360 e-ASPECTS. This device is classified as a Computer-assisted Diagnostic Software For Lesions Suspicious For Cancer (Class II - Special Controls, product code POK).
Submitted by Brainomix Limited (Oxford, GB). The FDA issued a Cleared decision on February 14, 2025, 119 days after receiving the submission on October 18, 2024.
This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.2060. Assist Users In Characterizing Lesions Identified On Acquired Medical Images.